These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 31203377)

  • 1. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium.
    Koivula RW; Forgie IM; Kurbasic A; Viñuela A; Heggie A; Giordano GN; Hansen TH; Hudson M; Koopman ADM; Rutters F; Siloaho M; Allin KH; Brage S; Brorsson CA; Dawed AY; De Masi F; Groves CJ; Kokkola T; Mahajan A; Perry MH; Rauh SP; Ridderstråle M; Teare HJA; Thomas EL; Tura A; Vestergaard H; White T; Adamski J; Bell JD; Beulens JW; Brunak S; Dermitzakis ET; Froguel P; Frost G; Gupta R; Hansen T; Hattersley A; Jablonka B; Kaye J; Laakso M; McDonald TJ; Pedersen O; Schwenk JM; Pavo I; Mari A; McCarthy MI; Ruetten H; Walker M; Pearson E; Franks PW;
    Diabetologia; 2019 Sep; 62(9):1601-1615. PubMed ID: 31203377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium.
    Koivula RW; Heggie A; Barnett A; Cederberg H; Hansen TH; Koopman AD; Ridderstråle M; Rutters F; Vestergaard H; Gupta R; Herrgård S; Heymans MW; Perry MH; Rauh S; Siloaho M; Teare HJ; Thorand B; Bell J; Brunak S; Frost G; Jablonka B; Mari A; McDonald TJ; Dekker JM; Hansen T; Hattersley A; Laakso M; Pedersen O; Koivisto V; Ruetten H; Walker M; Pearson E; Franks PW;
    Diabetologia; 2014 Jun; 57(6):1132-42. PubMed ID: 24695864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.
    RISE Consortium
    Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
    Sandforth A; von Schwartzenberg RJ; Arreola EV; Hanson RL; Sancar G; Katzenstein S; Lange K; Preißl H; Dreher SI; Weigert C; Wagner R; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Katsouli N; Ntziachristos V; Dannecker C; Fritsche L; Perakakis N; Heni M; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Stumvoll M; Schwarz PEH; Hauner H; Lechner A; Seissler J; Yurchenko I; Icks A; Solimena M; Häring HU; Szendroedi J; Schürmann A; de Angelis MH; Blüher M; Roden M; Bornstein SR; Stefan N; Fritsche A; Birkenfeld AL
    Lancet Diabetes Endocrinol; 2023 Nov; 11(11):798-810. PubMed ID: 37769677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study.
    Koivula RW; Atabaki-Pasdar N; Giordano GN; White T; Adamski J; Bell JD; Beulens J; Brage S; Brunak S; De Masi F; Dermitzakis ET; Forgie IM; Frost G; Hansen T; Hansen TH; Hattersley A; Kokkola T; Kurbasic A; Laakso M; Mari A; McDonald TJ; Pedersen O; Rutters F; Schwenk JM; Teare HJA; Thomas EL; Vinuela A; Mahajan A; McCarthy MI; Ruetten H; Walker M; Pearson E; Pavo I; Franks PW;
    Diabetologia; 2020 Apr; 63(4):744-756. PubMed ID: 32002573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial.
    Garrib A; Kivuyo S; Bates K; Ramaiya K; Wang D; Majaliwa E; Simbauranga R; Charles G; van Widenfelt E; Luo H; Alam U; Nyirenda MJ; Jaffar S; Mfinanga S;
    Diabetologia; 2023 Oct; 66(10):1882-1896. PubMed ID: 37460828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.
    Warren B; Pankow JS; Matsushita K; Punjabi NM; Daya NR; Grams M; Woodward M; Selvin E
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):34-42. PubMed ID: 27863979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal of medications leads to worsening of OGTT parameters in youth with impaired glucose tolerance or recently-diagnosed type 2 diabetes.
    Hannon TS; Edelstein SL; Arslanian SA; Caprio S; Zeitler PS; Buchanan TA; Ehrmann DA; Mather KJ; Tripputi M; Kahn SE; Nadeau KJ;
    Pediatr Diabetes; 2020 Dec; 21(8):1437-1446. PubMed ID: 32985775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
    Wittert G; Bracken K; Robledo KP; Grossmann M; Yeap BB; Handelsman DJ; Stuckey B; Conway A; Inder W; McLachlan R; Allan C; Jesudason D; Fui MNT; Hague W; Jenkins A; Daniel M; Gebski V; Keech A
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):32-45. PubMed ID: 33338415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-specific clinical outcomes of impaired glucose status: A long follow-up from the Tehran Lipid and Glucose Study.
    Parizadeh D; Rahimian N; Akbarpour S; Azizi F; Hadaegh F
    Eur J Prev Cardiol; 2019 Jul; 26(10):1080-1091. PubMed ID: 30862232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study.
    Ligthart S; van Herpt TT; Leening MJ; Kavousi M; Hofman A; Stricker BH; van Hoek M; Sijbrands EJ; Franco OH; Dehghan A
    Lancet Diabetes Endocrinol; 2016 Jan; 4(1):44-51. PubMed ID: 26575606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the postload-fasting glucose gap be used to determine risk of developing diabetes in chinese adults: A prospective cohort study.
    Xu X; Wang D; Jaffar S; Alam U; Qiu S; Xie B; Zhou X; Sun Z; Garrib A
    Diabetes Res Clin Pract; 2024 Jul; 213():111761. PubMed ID: 38950783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.
    Carlsson LMS; Sjöholm K; Karlsson C; Jacobson P; Andersson-Assarsson JC; Svensson PA; Larsson I; Hjorth S; Neovius M; Taube M; Carlsson B; Peltonen M
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):271-279. PubMed ID: 28237791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Ceramides and Other Sphingolipids in Relation to Incident Prediabetes in a Longitudinal Biracial Cohort.
    Dagogo-Jack S; Asuzu P; Wan J; Grambergs R; Stentz F; Mandal N
    J Clin Endocrinol Metab; 2024 Sep; 109(10):2530-2540. PubMed ID: 38501230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.
    Munkhaugen J; Hjelmesæth J; Otterstad JE; Helseth R; Sollid ST; Gjertsen E; Gullestad L; Perk J; Moum T; Husebye E; Dammen T
    BMC Cardiovasc Disord; 2018 Aug; 18(1):160. PubMed ID: 30075751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study.
    den Biggelaar LJ; Sep SJ; Eussen SJ; Mari A; Ferrannini E; van Greevenbroek MM; van der Kallen CJ; Schalkwijk CG; Stehouwer CD; Dagnelie PC
    Diabetologia; 2017 Mar; 60(3):432-441. PubMed ID: 27933333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inadequate Vitamin C Status in Prediabetes and Type 2 Diabetes Mellitus: Associations with Glycaemic Control, Obesity, and Smoking.
    Wilson R; Willis J; Gearry R; Skidmore P; Fleming E; Frampton C; Carr A
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28891932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.
    Mozaffarian D; Marfisi R; Levantesi G; Silletta MG; Tavazzi L; Tognoni G; Valagussa F; Marchioli R
    Lancet; 2007 Aug; 370(9588):667-75. PubMed ID: 17720018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying glucose thresholds for incident diabetes by physiological analysis: a mathematical solution.
    Ferrannini E; Manca ML
    Am J Physiol Regul Integr Comp Physiol; 2015 Apr; 308(7):R590-6. PubMed ID: 25552659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.